Advanced Medical Care Program for the Rapid Introduction of Healthcare Technologies to the National Health Insurance System in Japan-Reference-Cited by-同舟云学术

Advanced Medical Care Program for the Rapid Introduction of Healthcare Technologies to the National Health Insurance System in Japan

Published:2020-02-27 Issue:4 Volume:13 Page:700-706
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Ueda Keiko¹,Sanada Shoji²,Uemura Naoto³

Affiliation:

1. Clinical Research Support Center The University of Tokyo Tokyo Japan

2. Department of Medical Innovation Academic Clinical Research Center Osaka University Hospital Osaka Japan

3. Department of Clinical Pharmacology and Therapeutics Faculty of Medicine Oita University Oita Japan

Funder

Osaka University

Oita University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12751

Reference14 articles.

1. Japanese universal health coverage: evolution, achievements, and challenges

2. Law on securing quality efficacy and safety of pharmaceuticals medical devices regenerative and cellular therapy products gene therapy products and cosmetics. Law No. 145 August 10 1960; Final Revisions: Law No. 69 June 13 2014.

3. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).Harmonised tripartite guideline: guideline for good clinical practice E6 (R2) (Current Step 4 version). (ICH 2016).

4. Japanese universal health care faces a crisis in cancer treatment

5. III. Advanced Medical Care B and Patient-proposed Health Services

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial;International Journal of Clinical Oncology;2023-12-19

2. Surveys of the Efficacy, Technical Difficulty, Ethics, and Dissemination of Splint/Orthosis Fabrication Using Thermoplastic Splint Sheets;Asian Journal of Occupational Therapy;2023

3. Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China;Frontiers in Oncology;2022-08-26